My Alzheimer's JourneyPart 151 - Biogen UpdatesGreg RowlandMay 15, 20261ShareThis article has been moved to Greg’s Alzheimer’s Research ReportGreg's Alzheimer's Research ReportBiogen UpdatesOn February 10, I wrote about Biogen’s Diranersen (BIIB080), an investigational drug designed to reduce the production of tau protein. Diranersen was developed by Ionis Pharmaceuticals. In late 2019…Read morea month ago · Greg RowlandPreviousNext
